Our vision at On Target Laboratories is to brighten the future for those fighting cancer by making cancer visible intraoperatively so it can be removed more completely with our cancer-targeted intraoperative molecular imaging agents.
We are an agile, tenacious, collaborative biotechnology start-up with a relentless focus on advancing real- time cancer imaging. Our end game is helping people fight cancer, boldly pushing boundaries to advance science, technology, and humanity.
Our intraoperative molecular imaging agents, based on the pioneering work of Purdue University’s Philip S. Low, PhD, illuminate cancerous tissue, which may enable surgeons to detect more cancer that otherwise may have been left behind.
CYTALUX (pafolacianine) injection, On Target’s first product, received FDA approval for ovarian cancer in November 2021 and lung cancer in December 2022. For more information visit www.ontargetlabs.com and www.cytalux.com. We are currently commercializing CYTALUX®, and scaling our team.
The Senior Clinical Research Associate (Sr CRA) serves as the primary liaison to clinical trial sites participating in On Target-sponsored studies. This role is responsible for managing site activities across all stages—qualification, initiation, monitoring, and close- out. The Sr CRA ensures patient recruitment, enrollment, and overall site performance are aligned with GCP, ICH guidelines, and company SOPs.
UNCONVENTIONAL THINKERS. People who have the courage to challenge the status quo when necessary and come up with a better way of doing things.
RELENTLESS ACHIEVERS. People who thrive in a fast-paced entrepreneurial environment and are creative problem solvers who overcome obstacles with successful solutions.
INSPIRATIONAL COLLABORATORS. People who bring diverse individuals together and build strong teams that can successfully work toward a common goal and achieve success.
On Target Laboratories, Inc., is an Equal Opportunity Employer. On Target Laboratories, Inc. does not discriminate based on race, religion, color, sex, gender identity, sexual orientation, age, non-disqualifying physical or mental disability, national origin, veteran status or any other basis covered by appropriate law. All employment is decided based on qualifications, merit, and business need.
Our vision at On Target Laboratories is to brighten the future for those fighting cancer by making cancer visible intraoperatively so it can be removed more completely with our cancer-targeted intraoperative molecular imaging agents.
We are an agile, tenacious, collaborative biotechnology start-up with a relentless focus on advancing real-time cancer imaging. Our end game is helping people fight cancer, boldly pushing boundaries to advance science, technology, and humanity.
Our intraoperative molecular imaging agents, based on the pioneering work of Purdue University’s Philip S. Low, PhD, illuminate cancerous tissue, which may enable surgeons to detect more cancer that otherwise may have been left behind.
CYTALUX (pafolacianine) injection, On Target’s first product, received FDA approval for ovarian cancer in November 2021 and lung cancer in December 2022. For more information visit www.ontargetlabs.com and www.cytalux.com.
To date, Cytalux has been used commercially in ~1,500 procedures, including over 1,000 in 2025 which represented 125% growth over 2024.
On Target Laboratories is seeking a proven Sales Representative to drive the adoption of Cytalux within applicable specialties. This challenging role requires robust and refined skills in launching new technology, ensuring comprehensive training, education, and adoption protocol, along with adaptability in a hospital operating room environment. The Sales Representative will own and ensure standardization of clinical adoption and excellence to drive utilization in the commercial sales organization, working in collaboration with education team, commercial team, and strategic partners. This position reports to the Regional Sales Director. A successful candidate will draw on their experience of launching disruptive technology, with a demonstrated track record of working with strategic partners.
UNCONVENTIONAL THINKERS. People who question why things are done, are always coming up with a better way, and are not intimidated by taking risks.
RELENTLESS ACHIEVERS. People who thrive in a fast-paced entrepreneurial environment and are adept problem solvers who develop creative solutions to overcome obstacles.
INSPIRATIONAL COLLABORATORS. People who bring others with them and build teams, who foster the strength which comes from diverse individuals working toward a common goal.
On Target Laboratories, Inc. is an Equal Opportunity Employer. On Target Laboratories, Inc. does not discriminate on the basis of race, religion, color, sex, gender identity, sexual orientation, age, non-disqualifying physical or mental disability, national origin, veteran status or any other basis covered by appropriate law. All employment is decided on the basis of qualifications, merit, and business need.
Our vision at On Target Laboratories is to brighten the future for those fighting cancer by making cancer visible intraoperatively so it can be removed more completely with our cancer-targeted intraoperative molecular imaging agents.
We are an agile, tenacious, collaborative biotechnology start-up with a relentless focus on advancing real-time cancer imaging. Our end game is helping people fight cancer, boldly pushing boundaries to advance science, technology, and humanity.
Our intraoperative molecular imaging agents, based on the pioneering work of Purdue University’s Philip S. Low, PhD, illuminate cancerous tissue, which may enable surgeons to detect more cancer that otherwise may have been left behind.
CYTALUX (pafolacianine) injection, On Target’s first product, received FDA approval for ovarian cancer in November 2021 and lung cancer in December 2022. For more information visit www.ontargetlabs.com and www.cytalux.com.
To date, Cytalux has been used commercially in ~1,500 procedures, including over 1,000 in 2025 which represented 125% growth over 2024.
On Target Laboratories is seeking a proven Sales Representative to drive the adoption of Cytalux within applicable specialties. This challenging role requires robust and refined skills in launching new technology, ensuring comprehensive training, education, and adoption protocol, along with adaptability in a hospital operating room environment. The Sales Representative will own and ensure standardization of clinical adoption and excellence to drive utilization in the commercial sales organization, working in collaboration with education team, commercial team, and strategic partners. This position reports to the Regional Sales Director. A successful candidate will draw on their experience of launching disruptive technology, with a demonstrated track record of working with strategic partners.
UNCONVENTIONAL THINKERS. People who question why things are done, are always coming up with a better way, and are not intimidated by taking risks.
RELENTLESS ACHIEVERS. People who thrive in a fast-paced entrepreneurial environment and are adept problem solvers who develop creative solutions to overcome obstacles.
INSPIRATIONAL COLLABORATORS. People who bring others with them and build teams, who foster the strength which comes from diverse individuals working toward a common goal.
On Target Laboratories, Inc. is an Equal Opportunity Employer. On Target Laboratories, Inc. does not discriminate on the basis of race, religion, color, sex, gender identity, sexual orientation, age, non-disqualifying physical or mental disability, national origin, veteran status or any other basis covered by appropriate law. All employment is decided on the basis of qualifications, merit, and business need.
Our vision at On Target Laboratories is to brighten the future for those fighting cancer by making cancer visible intraoperatively so it can be removed more completely with our cancer-targeted intraoperative molecular imaging agents.
We are an agile, tenacious, collaborative biotechnology start-up with a relentless focus on advancing real-time cancer imaging. Our end game is helping people fight cancer, boldly pushing boundaries to advance science, technology, and humanity.
Our intraoperative molecular imaging agents, based on the pioneering work of Purdue University’s Philip S. Low, PhD, illuminate cancerous tissue, which may enable surgeons to detect more cancer that otherwise may have been left behind.
CYTALUX (pafolacianine) injection, On Target’s first product, received FDA approval for ovarian cancer in November 2021 and lung cancer in December 2022. For more information visit www.ontargetlabs.com and www.cytalux.com.
To date, Cytalux has been used commercially in ~1,500 procedures, including over 1,000 in 2025 which represented 125% growth over 2024.
On Target Laboratories is seeking a proven Sales Representative to drive the adoption of Cytalux within applicable specialties. This challenging role requires robust and refined skills in launching new technology, ensuring comprehensive training, education, and adoption protocol, along with adaptability in a hospital operating room environment. The Sales Representative will own and ensure standardization of clinical adoption and excellence to drive utilization in the commercial sales organization, working in collaboration with education team, commercial team, and strategic partners. This position reports to the Regional Sales Director. A successful candidate will draw on their experience of launching disruptive technology, with a demonstrated track record of working with strategic partners.
UNCONVENTIONAL THINKERS. People who question why things are done, are always coming up with a better way, and are not intimidated by taking risks.
RELENTLESS ACHIEVERS. People who thrive in a fast-paced entrepreneurial environment and are adept problem solvers who develop creative solutions to overcome obstacles.
INSPIRATIONAL COLLABORATORS. People who bring others with them and build teams, who foster the strength which comes from diverse individuals working toward a common goal.
On Target Laboratories, Inc. is an Equal Opportunity Employer. On Target Laboratories, Inc. does not discriminate on the basis of race, religion, color, sex, gender identity, sexual orientation, age, non-disqualifying physical or mental disability, national origin, veteran status or any other basis covered by appropriate law. All employment is decided on the basis of qualifications, merit, and business need.